-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Prostate cancer is one of the leading causes of cancer death in men.
Abnormal activation of PI3K-AKT signaling pathway caused by PTEN deletion is the most common driver of prostate cancer
Intermittent BAY1082439 treatment converts "cold" tumors to "hot" tumors and promotes ICT therapy efficacy
Given that abnormal activation of the PI3K pathway is the most commonly upregulated signaling pathway in cancer, this study also provides a preclinical basis for the application of PI3K inhibitor-targeted therapy and combined immunotherapy for other tumors
Wu Hong is the corresponding author of this article